Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 395-396

  Roux, Sophie ^a   Seelig, Hans Peter ^a   Meyer, Olivier ^a  

^a Bichat Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; MI 2 ANTIBODIES; MI-2 ANTIBODIES;

ADULT; AGED; BLOOD; DERMATOMYOSITIS; FEMALE; HUMAN; IMMUNOLOGY; LETTER; MALE; MIDDLE AGED; POLYMYOSITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMYOSITIS;

EID: 0031989885     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985;28:796-803.
2. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specifïc Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995;38:1389-99.
3. Seelig HP, Renz M, Targoff IN, Ge Q, Frank MB. Two forms of the major antigenic protein of the dermatomyositis-specifïc Mi-2 autoantigen [letter]. Arthritis Rheum 1996;39:1769-71.
4. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositisspecific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
5. Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E. Strong association of dermatomyositis-specifïc Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR chain. Arthritis Rheum 1996;39:868-76.